Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”

783 pharma patents match "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 783
Index total 30,257
Page 12 / 33

Quick answer

This filtered view shows 783 pharmaceutical patents matching "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

783 results for “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE” · 30,257 patents in full index Clear search

  1. US 8735407

    Purine derivatives as A3 adenosine receptor-selective agonists

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

    granted
  2. US 8735369

    Compositions and methods for inhibiting expression of a gene from the Ebola virus

    The United States of America as represented by the Secretary of the Army · Granted May 27, 2014 · Expires May 22, 2034

    granted
  3. US 8729053

    Nuclear factor kappa B pathway inhibitor composition and use of same

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 20, 2014 · Expires May 15, 2034

    granted
  4. US 8722046

    Human monoclonal antibodies protective against bubonic plague

    The United States of America as represented by the Secretary of the Army · Granted May 13, 2014 · Expires May 8, 2034

    granted
  5. US 8715751

    Artemisinins in the clinical and veterinary management of kinetoplastid infections

    The United States of America as represented by the Secretary of the Army · Granted May 6, 2014 · Expires May 1, 2034

    granted
  6. US 8716315

    Analogs of thalidomide as potential angiogenesis inhibitors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted
  7. US 8715689

    Chimeric west nile/dengue viruses

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted May 6, 2014 · Expires May 1, 2034

    granted
  8. US 8709487

    Nanoparticle entrapment of materials

    The United States of America as represented by the Secretary of the Army · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted
  9. US 8710185

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted
  10. US 8703826

    Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted
  11. US 8703096

    Beta-amyloid PET imaging agents

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted
  12. US 8697856

    Plasmodium vivax hybrid circumsporozoite protein and vaccine

    The United States of America as represented by the Secretary of the Army · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted
  13. US 8691859

    Broad spectrum antibacterial compounds

    The United States of America as represented by the Secretary of the Army · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  14. US 8691501

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  15. US 8685411

    Rotavirus antigens

    The United States of America as represented by the Dept. of Health and Human Services (DHHS) · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted
  16. US 8680066

    Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject

    The United States of America as represented by the Development of Veterans Affairs · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted
  17. US 8680046

    Inhibitors of viral integrase and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted
  18. US 8673629

    Recombinant Rift Valley fever (RVF) viruses and methods of use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  19. US 8663968

    Simian T-cell lymphotropic virus

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  20. US 8652458

    Tissue graft with non-aligned fiber matrix retains mesenchymal progenitor cells on the non-injury-facing side

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  21. US 8647633

    Recombinant F1-V plague vaccine

    The United States of America as represented by the Secretary of the Army · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  22. US 8642048

    Multiple antigenic peptides immunogenic against Streptococcus pneumonia

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted
  23. US 8636997

    Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted
  24. US 8637560

    Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted